Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cardiac myocyte repolarization is the process by which cardiac muscle cells restore their negative resting membrane potential after depolarization and contraction. This phase, mainly corresponding to phase 3 of the cardiac action potential, is orchestrated predominantly by the opening of various potassium (K⁺) channels, closing of calcium (Ca²⁺) channels, and activity of ion exchangers and pumps such as the sodium-potassium pump. Multiple ion channel types are involved, especially the delayed rectifier potassium channels (such as I_Kr and I_Ks) and inward rectifier K⁺ channels. Disruption of this process, by either genetic or pharmacological factors, can lead to abnormal cardiac rhythms and is a primary cause of acquired or inherited long QT syndrome, making the constituent ion channels the true therapeutic targets, not the process itself.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cardiac myocyte repolarization.